Mostrar el registro sencillo del ítem

dc.contributor.authorCamargo, Loidaspa
dc.contributor.authorHerrera-Pino, Jorge Alfredospa
dc.contributor.authorShelach , Salomonspa
dc.contributor.authorSoto-Añari, Marciospa
dc.contributor.authorPorto, María F.spa
dc.contributor.authorALONSO, MONICAspa
dc.contributor.authorGonzález, Miguelspa
dc.contributor.authorContreras, Oscarspa
dc.contributor.authorCaldichoury, Nicolespa
dc.contributor.authorRamos-Henderson, Miguelspa
dc.contributor.authorGARGIULO, Pascualspa
dc.contributor.authorLópez, Normanspa
dc.date.accessioned2021-11-23T19:17:11Z
dc.date.available2021-11-23T19:17:11Z
dc.date.issued2021
dc.identifier.issn0034-7450spa
dc.identifier.urihttps://hdl.handle.net/11323/8897spa
dc.description.abstractIntroduction: The detection of anxiety symptoms among health workers who care for patients infected with COVID-19 is a current priority. Fast and valid instruments are required for this population group. The objective is to establish the construct validity and reliability of the Generalised Anxiety Disorder (GAD-7) scale in Colombian doctors during the COVID-19 lockdown. Methods: E-health study, in which cross-sectional data were collected online (n= 1,030) from 610 COVID doctors and 420 non-COVID doctors, during the Colombian lockdown, between 20 April and 10 August 2020. Each subject was contacted, and they confirmed their participation, identity and professional role. Results: A single factor factorial structure was found, made up of the 7 items of the instrument, which managed to explain 70% of the variance. The goodness of fit indices (RMSEA = 0.080; CFI = 0.995; SRMR = 0.053; p < 0.001) showed an “acceptable” unidimensionality and adequate factor loadings in each item of the GAD-7, >0.070. Finally, the internal consistency of the instrument was good, with a Cronbach’s alpha of 0.920 (95%IC, 8.80-9.71). Conclusions: The GAD-7 is an instrument that presents adequate indicators of validity and reliability. It is an excellent tool that is reliable and easy and fast to use for the detection of generalised anxiety symptoms in medical personnel caring (or not) for patients infected with COVID-19.spa
dc.description.abstractIntroducción: La detección de síntomas de ansiedad entre el personal sanitario que atiende a pacientes contagiados de COVID-19 es una prioridad actual. Se requieren instrumentos rápidos y válidos para esta población. El objetivo es establecer la validez de constructo y la confiabilidad de la Escala de Ansiedad Generalizada (GAD-7) en médicos colombianos durante la cuarentena por la COVID-19. Métodos: Estudio eSalud, en el que se recopilaron datos transversales en línea (n= 1.030) de 610 médicos de COVID y 420 no de COVID durante la cuarentena colombiana, entre el 20 de abril y el 10 de agosto de 2020. Se contactó con cada sujeto, que confirmó participación, identidad y función profesional. Resultados: Se encontró una estructura factorial de 1 solo factor, conformado por los 7 ítems del instrumento, que logró explicar el 70% de la varianza. Los índices de bondad de ajuste (RMSEA = 0,080; CFI = 0,995; SRMR = 0,053; p < 0,001) mostraron una unidimensionalidad «aceptable» y adecuadas cargas factoriales en cada ítem del GAD-7, > 0,07. Por último, la consistencia interna del instrumento fue buena, con alfa de Cronbach= 0,920 (IC95%, 8,80-9,71). Conclusiones: El GAD-7 es un instrumento que presenta indicadores adecuados de validez y confiabilidad. Es un excelente instrumento, confiable, fácil y rápido de usar para la detección de los síntomas de ansiedad generalizada en personal médico, atienda o no a pacientes contagiados de COVID-19.spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospa
dc.publisherCorporación Universidad de la Costaspa
dc.rightsCC0 1.0 Universalspa
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/spa
dc.sourceRevista Colombiana de Psiquiatríaspa
dc.subjectGAD-7spa
dc.subjectAnxietyspa
dc.subjectPsychometricsspa
dc.subjectCOVID-19spa
dc.subjectHealth workersspa
dc.subjectAnsiedadspa
dc.subjectPsicometríaspa
dc.subjectPersonal sanitariospa
dc.titleEscala de ansiedad generalizada GAD-7 en profesionales médicos colombianos durante pandemia de COVID-19: validez de constructo y confiabilidadspa
dc.typeArtículo de revistaspa
dc.source.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249708/spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.identifier.doihttps://doi.org/10.1016/j.rcp.2021.06.003spa
dc.identifier.instnameCorporación Universidad de la Costaspa
dc.identifier.reponameREDICUC - Repositorio CUCspa
dc.identifier.repourlhttps://repositorio.cuc.edu.co/spa
dc.relation.references1. Asociación Americana de Psiquiatría. Manual diagnóstico y estadístico de los trastornos mentales: DSM-5. APA; 2014.spa
dc.relation.references2. Phillips KA, Friedman MJ, Stein DJ, Craske M. Special DSM-V issues on anxiety, obsessive-compulsive spectrum, posttraumatic, and dissociative disorders. Depress Anxiety. 2010;27:91–2.spa
dc.relation.references3. Danet Danet A. Psychological impact of COVID-19 pandemic in Western frontline healthcare professionals. A systematic review. Med Clin (Barc). 2021.spa
dc.relation.references4. Alonso J, Vilagut G, Mortier P, Ferrer M, Alayo I, Aragón-Pena˜ A, et al. Mental health impact of the first wave of COVID-19 pandemic on Spanish healthcare workers: A large cross-sectional survey. Rev Psiquiatria Salud Mental. 2021.spa
dc.relation.references5. Zheng R, Zhou Y, Qiu M, Yan Y, Yue J, Yu L, et al. Prevalence and associated factors of depression, anxiety, and stress among Hubei pediatric nurses during COVID-19 pandemic. Comprehens Psychiatry. 2021:104.spa
dc.relation.references6. Liu CY, Yang YZ, Zhang XM, Xu X, Dou QL, Zhang W, et al. The prevalence and influencing factors in anxiety in medical workers fighting COVID-19 in China: A cross-sectional survey. Epidemiol Infect. 2020:148.spa
dc.relation.references7. Feinstein RE, Kotara S, Jones B, Shanor D, Nemeroff CB. A health care workers mental health crisis line in the age of COVID-19. Depress Anxiety. 2020;37:822–6.spa
dc.relation.references8. da Silva FCT, Neto MLR. Psychological effects caused by the COVID-19 pandemic in health professionals: A systematic review with meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021:104.spa
dc.relation.references9. Thombs BD, Saadat N, Riehm KE, Karter JM, Vaswani A, Andrews BK, et al. Consistency and sources of divergence in recommendations on screening with questionnaires for presently experienced health problems or symptoms: A comparison of recommendations from the Canadian Task Force on Preventive Health Care UK National Screening Committee, and US Preventive Services Task Force. BMC Medicine. 2017;15:150.spa
dc.relation.references10. Cassiani-Miranda CA, Cuadros-Cruz AK, Torres-Pinzón H, Scoppetta O, Pinzón-Tarrazona JH, López-Fuentes WY, et al. Validity of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adult primary care users in Bucaramanga. Colombia. Rev Colomb Psiquiatr. 2021;50:11–21.spa
dc.relation.references11. Scoppetta O, Cassiani-Miranda CA, Arocha-Díaz KN, Cabanzo-Arenas DF, Campo-Arias A. Validity of the patient health questionnaire-2 (PHQ-2) for the detection of depression in primary care in Colombia. J Affect Disord. 2021;278:576–82.spa
dc.relation.references12. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166:1092–7.spa
dc.relation.references13. Ahn J-K, Kim Y, Choi K-H. The psychometric properties and clinical utility of the Korean version of GAD-7 and GAD-2. Front Psychiatry. 2019;10:127.spa
dc.relation.references14. Gong Y, Zhou H, Zhang Y, Zhu X, Wang X, Shen B, et al. Validation of the 7-item Generalized Anxiety Disorder scale (GAD-7) as a screening tool for anxiety among pregnant Chinese women. J Affect Disord. 2021;282:98–103.spa
dc.relation.references15. Hinz A, Klein AM, Brähler E, Glaesmer H, Luck T, Riedel-Heller SG, et al. Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample. J Affect Disord. 2017;210:338–44.spa
dc.relation.references16. Monterrosa-Castro A, Redondo-Mendoza V, Mercado-Lara M. Psychosocial factors associated with symptoms of generalized anxiety disorder in general practitioners during the COVID-19 pandemic. J Invest Med. 2020;68:1228–34.spa
dc.relation.references17. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.spa
dc.relation.references18. García-Campayo J, Zamorano E, Ruiz MA, Pardo A, Pérez-Páramo M, López-Gómez V, et al. Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes. 2010:8.spa
dc.relation.references19. Masuyama A, Shinkawa H, Kubo T. Validation and psychometric properties of the Japanese version Fear of COVID-19 Scale among adolescents. 2020. Disponible en: https://psyarxiv.com/jkmut/. Consultado 25 Mar 2021.spa
dc.relation.references20. Munoz-Navarro ˜ R, Cano-Vindel A, Moriana JA, Medrano LA, Ruiz-Rodríguez P, Agüero-Gento L, et al. Screening for generalized anxiety disorder in Spanish primary care centers with the GAD-7. Psychiatr Res. 2017;256:312–7.spa
dc.relation.references21. Seo JG, Park SP. Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. J Headache Pain. 2015;16:1–7.spa
dc.relation.references22. Zhong QY, Gelaye B, Zaslavsky AM, Fann JR, Rondon MB, Sánchez SE, et al. Diagnostic validity of the generalized anxiety disorder-7 (GAD-7) among pregnant women. PLoS ONE. 2015;10:125096.spa
dc.relation.references23. Jordan P, Shedden-Mora MC, Löwe B. Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7) in primary care using modern item response theory. PLoS ONE. 2017;12(8.).spa
dc.relation.references24. Esser P, Hartung TJ, Friedrich M, Johansen C, Wittchen HU, Faller H. The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients. Psycho-Oncol. 2018;27:1509–16.spa
dc.relation.references25. Teo WZY, Soo YE, Yip C, Lizhen O, Chun-Tsu L. The psychological impact of COVID-19 on ‘hidden’ frontline healthcare workers. Int J Soc Psychiatry. 2020. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32779498/.spa
dc.relation.references26. Osman A, Wong JL, Bagge CL, Freedenthal S, Gutierrez PM, Lozano G. The Depression Anxiety Stress Scales-21 (DASS-21): further examination of dimensions, scale reliability, and correlates. J Clin Psychol. 2012;68:1322–38.spa
dc.relation.references27. Ma Y, Rosenheck R, He H. Psychological stress among health care professionals during the 2019 novel coronavirus disease Outbreak: Cases from online consulting customers. Intens Crit Care Nurs. 2020;61:102905.spa
dc.title.translatedGAD-7 Generalised Anxiety Disorder scale in Colombian medical professionals during the COVID-19 pandemic: construct validity and reliabilityspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Ficheros en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos científicos [3154]
    Artículos de investigación publicados por miembros de la comunidad universitaria.

Mostrar el registro sencillo del ítem

CC0 1.0 Universal
Excepto si se señala otra cosa, la licencia del ítem se describe como CC0 1.0 Universal